Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
Ritsuko Kubota-Koketsu,1,2,* Mikihiro Yunoki,3,* Yoshinobu Okuno,4 Kazuyoshi Ikuta1 1Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; 2Surveillance Section, Research and Production Technology Department, The Research Foundation for Microbial Diseases...
Guardado en:
Autores principales: | Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d3562c247f94f799dbfa4d62bf4a95e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus
por: Yunoki M, et al.
Publicado: (2016) -
Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
por: Onodera H, et al.
Publicado: (2017) -
Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010
por: Ikuta K, et al.
Publicado: (2012) -
Intravenous Immunoglobulin and its Complications
por: I Mohammadzadeh
Publicado: (2011) -
Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections
por: Ivette A. Nuñez, et al.
Publicado: (2021)